Dermalaczyn®

Probiotic Solution for
Pediatric Atopic Dermatitis

mother and baby

Key marketing aspects

  • targeting the most frequent allergic disease in children
  • unique combination of patented probiotic strains specifically selected for the treatment of atopic dermatitis and for restoring the allergic immune system
  • plus vitamin D – health claim related to the normal function of the immune system and inflammatory response
  • 50% less allergy symptoms (pruritus, sleep loss, redness, swelling)
  • less emotional stress
  • alternative or add-on therapy to corticosteroids
  • clinically tested in children
  • high acceptance in children
  • pharmacy exclusive

Facts

  • randomized, placebo-controlled clinical trial (RCT) demonstrating significant reduction in clinical symptoms of atopic dermatitis in children
  • additional 3 RCTs published demonstrating improvements of other allergy symptoms
  • vitamin D modulates the immune response and helps alleviating symptoms of atopic dermatitis
  • stimulating the Th1 immune response (INF-γ) and reducing key mediators (IL-4 & IgE) of allergic response

How to use

  • lozenge: children above 3 years of age
  • sachet: children under 3 years of age
  • once a day
  • add-on to emollient & topical corticosteroids
sachet packging DermaLacZyn®

DermaLacZyn®  is a registered trademark of BLUESTONE PHARMA GmbH